The AI infrastructure for women's health

Care is complex,
Ema guides what's next.

The fastest, safest way to launch women's health AI. Our partners use Ema as their AI or layer it onto the AI they already have, then scale trusted capabilities for years.

emaeq

Why Ema exists

Generic AI wasn't built for care.

~60%

That's the failure rate across leading AI models. 13 state-of-the-art LLMs failed roughly 60% of the time on a women's health benchmark — because generic AI was never built for care.

Gruber et al., A Women's Health Benchmark for Large Language Models, arXiv 2025.

Problem

Generic AI is
well, generic.

Most AI answers questions. It doesn't understand clinical context, care gaps, or patient identity, and it has no idea what to do inside our partners' technology.

Solution

Ema is built for women from the start.

Trained on women's health, one of the most complex, nuanced, historically underserved areas of care. Ema's AI reflects that depth of understanding.

Expansion

Now Ema is scaled for everyone.

Because we mastered the complexity of women's health, Ema is uniquely equipped to handle any care journey, from men's health to chronic conditions.

We built the first agentic AI for women, circa 2020.

What is Ema

Clinically accurate, purpose-built AI.

Ema creates user flow experiences in a health company's technology they didn't know was possible.

100+ agentic capabilities Lives inside our partners' product

CYCLE DATASYMPTOMSBEHAVIORAL PATTERNSPURCHASING BEHAVIORCLINICAL ASSESSMENTSEMRBIOMETRICSMENTAL HEALTH INDICATORSCONTENT CONSUMPTIONPARTNER APISINTAKE DATA

EMA'S ACTIONABLE INSIGHT

Your HRV has dropped 15% this week and your check-in logs show low mood + energy.

This could be early postpartum depletion. Let's schedule a mental health screen.

BUSINESS ROI98% Retention

Commercialization partners

Trusted by leading health companies.

Ema drives outcomes across product, care, and operations.

Some Ema capabilities our clients leverage:

Decision support & resources Connected care navigation Mental & emotional support Wearable symptom relief Hormone & cycle insights Menopause guidance Peer & community support Lactation coaching + many more

Impact

0%prefer Ema to Google, driving higher engagement and retention

0%of conversations increased product and service utilization

0%reduction in operational load for care teams

Inside the layer

Ema's tech stack is proprietary at every layer.

Our partners' Ema's (proprietary) Frontier LLM · swappable Ema acts across our partners' systems

The base model is a hybrid: a frontier LLM with Ema's reasoning models, RAG, and clinical brain on top. Ema is in our partners' model even when the base model is theirs.

Our partners also get our team to white label the product for them.

Our partners' model, maintained

A dedicated team monitors, retrains, and tunes the model behind our partners' product as their users and data evolve.

Continuous core upgrades

Every improvement to the Ema core flows to you automatically. You inherit the roadmap instead of rebuilding it.

AI biologist

Women's-health scientists keep the clinical intelligence current, evidence-based, and aligned to the latest research.

AI UI/UX designer

Design partners shape how the experience looks, feels, and converts inside our partners' product.

Data analytics

Ema unlocks data insights our partners' companies have never seen before.

She doesn't just analyze data, she generates it, turning raw conversations into intelligence our partners can act on.

EngagementSentimentHEDIS measuresSDOHConversionTopic trends

100% of user data stays owned by our partners. PHI is redacted and encrypted, and our partners' data never trains Ema's core models.

Click the tabs to explore

Acme Health System3-Year Program Analysis

EMA DATA-ANALYST

11,000

Total Population

+8% YoY

68%

Avg Engagement

+16% vs Y1

76%

AI Predicted Q1

+8% Growth

3 yrs

Program Years

Rich dataset

Top recommendations

92% confidence

Optimal launch window

February shows 23% higher engagement for chronic-care cohorts, based on 3-year pattern analysis.

88% confidence

Target cohort

Preventive-care group (ages 36 to 50) shows the highest engagement potential, with 85% predicted participation.

"Finally something that explained my perimenopause symptoms without making me feel dismissed."

PositiveMenopause

"I was so confused about my cycle, and the guidance actually made sense for me."

PositiveFertility

"Felt heard at 2am when I couldn't reach anyone else."

PositiveMental health

"Took a couple of tries to find the right answer about postpartum recovery."

NeutralPostpartum

"Wish it could book the appointment for me, not just suggest it."

NeutralMental health

"Knowing a clinician reviewed the answer made me trust it."

PositiveFertility

Three ways to build with Ema.

01 · DIY

Self-serve API

Use Ema's API to build new health experiences and products on top of the platform. Our partners build on Ema.

Most common

02 · Together

Co-build

We build it together, our partners' team and Ema's, side by side, into their existing flow.

03 · Done for you

Fully managed

The Ema team builds the whole solution for our partners, with supported onboarding and ready-made capabilities.

Two ways Ema fits our partners' architecture

Ema is the intelligence system for our partners' whole tech stack.

It is the same Ema layer either way; only what surrounds it changes. Our partners train it once, and their models, data, and configurations stay theirs.

Why teams trust Ema

Built for the next decade of healthcare.

10M+

User interactions

HIPAA, GDPR & SOC 2

Enterprise-grade security

Benchmarked

Against clinical guidelines

Female founded

and led

🏆Femtech World — Winner

✨AI Innovation of the Year, 2025

Strategic partners

Recognized by

We wrote the standard.

Ema co-founded the Women's Health AI Consortium (WHAI), the first industry body to set shared benchmarks, ethical standards, and transparent evaluation for women's health AI, governed by six commitments spanning safety, bias reduction, clinical quality, longitudinal intelligence, mentorship, and transparent oversight.

Financial status

ARR growth trajectory & pipeline.

ARR Growth: 2025–2028

$563K

2025

$2.5M

YE 26

$7.5M

YE 27

$20M

YE 28

2025 ActualProjected

*Totals in chart above are cumulative

✦Growth Metrics

2025 Q4 ARR

$562K

Q1 → Q4 Growth

326%

✦Active Pipeline

$12M

Total Pipeline Value

Avg Deal Size$125K

Pipeline / ARR21x

25/26' Pipeline Verticals

Pharma
Diagnostics
Women's Health & Wellness Brands

$2M

Signed in actual contract value in 2025

The team

Industry leaders in AI, experts in women's health.

Impact

Our Tri-Impact Model.

Where better data, smarter care, and revenue intersect.

For Partners

For End Users

For Broader Women's Health System

Admin & Cost load

Screening Rates, Red Flag Detection, Utilization, Education, Revenue

Data Insights (like HEDIS, Behavioral, Health Outcomes)

Education & Health Outcomes

Cost of Health & Wellness

Trust & Ability to Self-Advocate & Self-Improve

Visibility into Population-Level Needs

Gaps in Women's Health Data

Insight to Inform Policy, Systems and AI to build

“Ema helped me know what's normal and what's not, that saved my life.”

L. Hess, Ema User

Let's build it together

One intelligence layer.

Build on Ema, layer it onto what they have, or let us build it for them. Our partners' models and data stay theirs — see Ema running inside their product in weeks, not quarters.

emahealth.ai · Built on evidence. Shaped by experts.

e

Chat with Emaletsconnect@emaapp.co

online

Care is complex,Ema guides what's next.